Cataia Ives
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Cataia Ives has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Wayne Huggins
Data Analytics & Digital Solutions, RTI International, Research Triangle Park, NC 27709
4 shared publications - Carol M. Hamilton
RTI International, Durham, USA
3 shared publications Barbara Kroner
Affiliation Analytics Practice Area, RTI International, Research Triangle Park, United States of America
2 shared publicationsCarol M. Hamilton
GenOmics, Bioinformatics, and Translation Research Center, RTI International, Research Triangle Park, North Carolina
2 shared publications- Huaqin Pan
RTI International, Research Triangle Park, NC, USA
2 shared publications Jeran Stratford
Affiliation Analytics Practice Area, RTI International, Research Triangle Park, United States of America
2 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
PhenX Toolkit: a knowledgebase that enables consistent data collection and facilitates cross-study analysis and data reuse
The PhenX (consensus measures for Phenotypes and eXposures) Toolkit (https://www.phenxtoolkit.org/) is a publicly available knowledgebase of well-established, broadly validated measurement protocols recommended for use in genomic, clinical, translational, and epidemiological research involving human participants. Consistent use of PhenX protocols, including questionnaires, bioassays, and physical assessments, improves the rigor, transparency, reproducibility, and comparability of research data. The Toolkit was recently highlighted in the National Institutes of Health (NIH) implementation plan, “Leading in Gold Standard Science,” as an example of efforts to advance reproducible biomedical research. The Toolkit currently includes 1010 protocols spanning a wide range of diseases, exposures, and study designs. Content development is guided by the scientific community through a consensus-based process involving expert Working Groups, community input, and strategic oversight from the PhenX Steering Committee. Collaborations with NIH Institutes have expanded Toolkit content in priority areas, including substance use and cardiovascular disease. The PhenX Toolkit enhances study design and supports implementation of selected protocols. PhenX also collaborates with resources that facilitate data collection (REDCap), data standards (LOINC), and data repositories to promote interoperability and cross-study analyses. To date, the Toolkit has been recommended in 711 NIH funding opportunities and cited in >1300 publications. Future directions are discussed.
- 3 November 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
Open AccessPhenX Toolkit: a knowledgebase that enables consistent data collection and facilitates cross-study analysis and data reuse
The PhenX (consensus measures for Phenotypes and eXposures) Toolkit (https://www.phenxtoolkit.org/) is a publicly available knowledgebase of well-established, broadly validated measurement protocols recommended for use in genomic, clinical, translational, and epidemiological research involving human participants. Consistent use of PhenX protocols, including questionnaires, bioassays, and physical assessments, improves the rigor, transparency, reproducibility, and comparability of research data. The Toolkit was recently highlighted in the National Institutes of Health (NIH) implementation plan, “Leading in Gold Standard Science,” as an example of efforts to advance reproducible biomedical research. The Toolkit currently includes 1010 protocols spanning a wide range of diseases, exposures, and study designs. Content development is guided by the scientific community through a consensus-based process involving expert Working Groups, community input, and strategic oversight from the PhenX Steering Committee. Collaborations with NIH Institutes have expanded Toolkit content in priority areas, including substance use and cardiovascular disease. The PhenX Toolkit enhances study design and supports implementation of selected protocols. PhenX also collaborates with resources that facilitate data collection (REDCap), data standards (LOINC), and data repositories to promote interoperability and cross-study analyses. To date, the Toolkit has been recommended in 711 NIH funding opportunities and cited in >1300 publications. Future directions are discussed.
- 11 December 2025
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 278, 113001
Enhancing data compatibility in an evolving landscape: Medical cannabis and polysubstance use protocols in the PhenX Toolkit
- 11 December 2025
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 278, 113001
Enhancing data compatibility in an evolving landscape: Medical cannabis and polysubstance use protocols in the PhenX Toolkit
- Open Access
- 23 April 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (4) , e0309572
CureSCi Metadata Catalog—Finding and harmonizing studies for secondary analysis of hydroxyurea discontinuation in sickle cell disease
Objectives: Sickle cell disease (SCD) is a rare group of inherited red blood cell disorders that affect hemoglobin, resulting in serious multi-system complications. The limited number of patients available to participate in research studies can inhibit investigating sophisticated relationships. Secondary analysis is a research method that involves using existing data to answer new research questions. Data harmonization enables secondary analysis by combining data across studies, especially helpful for rare disease research where individual studies may be small. The National Heart, Lung, and Blood Institute Cure Sickle Cell Initiative (CureSCi) Metadata Catalog is a web-based tool to identify SCD study datasets for conducting data harmonization and secondary analysis. We present a proof-of-concept secondary analysis to explore factors associated with discontinuation of hydroxyurea, a safe and effective first line SCD therapy, to illustrate the utility of the CureSCi Metadata Catalog to expedite and enable more robust SCD research. Methods: We performed secondary analysis of SCD studies using a multi-step workflow: develop research questions, identify study datasets, identify variables of interest, harmonize variables, and establish an analysis method. A harmonized dataset consisting of eight predictor variables across five studies was created. Secondary analysis employed a generalized linear model to identify factors that significantly impact hydroxyurea discontinuation. Results: The CureSCi Metadata Catalog provided a platform to efficiently find relevant studies and design a harmonization strategy to prepare data for secondary analysis. Multivariate analysis of the harmonized data identified that patients who were female, had a history of blood transfusion therapy, experiencing pain, and had the SC sickle cell genotype are more likely to stop hydroxyurea treatment. Conclusion: This secondary analysis provides a template for how the CureSCi Metadata Catalog expedites dataset discovery of sickle cell studies for identifying relationships between variables or validating existing findings.
- 23 April 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (4) , e0309572
Open AccessCureSCi Metadata Catalog—Finding and harmonizing studies for secondary analysis of hydroxyurea discontinuation in sickle cell disease
Objectives: Sickle cell disease (SCD) is a rare group of inherited red blood cell disorders that affect hemoglobin, resulting in serious multi-system complications. The limited number of patients available to participate in research studies can inhibit investigating sophisticated relationships. Secondary analysis is a research method that involves using existing data to answer new research questions. Data harmonization enables secondary analysis by combining data across studies, especially helpful for rare disease research where individual studies may be small. The National Heart, Lung, and Blood Institute Cure Sickle Cell Initiative (CureSCi) Metadata Catalog is a web-based tool to identify SCD study datasets for conducting data harmonization and secondary analysis. We present a proof-of-concept secondary analysis to explore factors associated with discontinuation of hydroxyurea, a safe and effective first line SCD therapy, to illustrate the utility of the CureSCi Metadata Catalog to expedite and enable more robust SCD research. Methods: We performed secondary analysis of SCD studies using a multi-step workflow: develop research questions, identify study datasets, identify variables of interest, harmonize variables, and establish an analysis method. A harmonized dataset consisting of eight predictor variables across five studies was created. Secondary analysis employed a generalized linear model to identify factors that significantly impact hydroxyurea discontinuation. Results: The CureSCi Metadata Catalog provided a platform to efficiently find relevant studies and design a harmonization strategy to prepare data for secondary analysis. Multivariate analysis of the harmonized data identified that patients who were female, had a history of blood transfusion therapy, experiencing pain, and had the SC sickle cell genotype are more likely to stop hydroxyurea treatment. Conclusion: This secondary analysis provides a template for how the CureSCi Metadata Catalog expedites dataset discovery of sickle cell studies for identifying relationships between variables or validating existing findings.
- Open Access
- 17 January 2025
- Published by Oxford University Press (OUP) in Journal of Sickle Cell Disease
- Vol. 2 (1)
Recommended measurement protocols for sickle cell disease in the PhenX toolkit: psychosocial factors and social determinants of health
Lay Summary: The PhenX Toolkit is an online resource that provides recommended measurement protocols to help with study design and data analysis. It lacked specific protocols for Sickle Cell Disease (SCD) related to psychosocial factors and social determinants of health (SDoH), which are important for improving SCD care. This paper outlines the process of selecting these protocols and presents final recommendations. A panel of experts in psychology, behavioral science, hematology, and nursing used a consensus method to identify and agree on the most important protocols. They initially developed 19 scope elements and reached consensus on 19 protocols, which were then shared for public comment. The final recommendations include 15 protocols that assess various indicators such as transition readiness, self-management, early aging impact, stigma, trust in medical care, resilience, spirituality, and stress responses. Additionally, 8 protocols were selected as supplemental information, and existing SDoH protocols in the Toolkit relevant to SCD were cross-listed. These new protocols enhance the SCD Research Collections and the SDoH Collections in the PhenX Toolkit, promoting the use of validated tools to study psychosocial factors and SDoH in SCD.
- 17 January 2025
- Published by Oxford University Press (OUP) in Journal of Sickle Cell Disease
- Vol. 2 (1)
Open AccessRecommended measurement protocols for sickle cell disease in the PhenX toolkit: psychosocial factors and social determinants of health
Lay Summary: The PhenX Toolkit is an online resource that provides recommended measurement protocols to help with study design and data analysis. It lacked specific protocols for Sickle Cell Disease (SCD) related to psychosocial factors and social determinants of health (SDoH), which are important for improving SCD care. This paper outlines the process of selecting these protocols and presents final recommendations. A panel of experts in psychology, behavioral science, hematology, and nursing used a consensus method to identify and agree on the most important protocols. They initially developed 19 scope elements and reached consensus on 19 protocols, which were then shared for public comment. The final recommendations include 15 protocols that assess various indicators such as transition readiness, self-management, early aging impact, stigma, trust in medical care, resilience, spirituality, and stress responses. Additionally, 8 protocols were selected as supplemental information, and existing SDoH protocols in the Toolkit relevant to SCD were cross-listed. These new protocols enhance the SCD Research Collections and the SDoH Collections in the PhenX Toolkit, promoting the use of validated tools to study psychosocial factors and SDoH in SCD.
- Open Access
CureSCi Metadata Catalog—finding and harmonizing studies for secondary analysis of hydroxyurea use for sickle cell disease
Objectives Sickle cell disease (SCD) is a rare group of inherited red blood cell disorders that affect hemoglobin, resulting in serious multi-system complications. The limited number of patients available to participate in research studies can inhibit investigating sophisticated relationships. Secondary analysis is a research method that involves using existing data to answer new research questions. Data harmonization enables secondary analysis by combining data across studies, especially helpful for rare disease research where individual studies may be small. The National Heart, Lung, and Blood Institute Cure Sickle Cell Initiative (CureSCi) Metadata Catalog is a web-based tool to identify SCD study datasets for conducting data harmonization and secondary analysis. We present a proof-of-concept secondary analysis to explore factors associated with discontinuation of hydroxyurea, a safe and effective first line SCD therapy, to illustrate the utility of the CureSCi Metadata Catalog to expedite and enable more robust SCD research. Methods We performed secondary analysis of SCD studies using a multi-step workflow: develop research questions, identify study datasets, identify variables of interest, harmonize variables, and establish an analysis method. A harmonized dataset consisting of eight predictor variables across five studies was created. Secondary analysis involved a generalized linear model was employed to identify factors that significantly impact hydroxyurea discontinuation. Results The CureSCi Metadata Catalog provided a platform to efficiently find relevant studies and design a harmonization strategy to prepare data for secondary analysis. Multivariate analysis of the harmonized identified that patients who are older, are female, had a history of blood transfusion therapy, had episodes of acute chest syndrome, and had the SC sickle cell genotype are more likely to stop hydroxyurea treatment. Conclusion This secondary analysis provides a template for how the CureSCi Metadata Catalog expedites dataset discovery of sickle cell studies for identifying relationships between variables or validating existing findings.
Open AccessCureSCi Metadata Catalog—finding and harmonizing studies for secondary analysis of hydroxyurea use for sickle cell disease
Objectives Sickle cell disease (SCD) is a rare group of inherited red blood cell disorders that affect hemoglobin, resulting in serious multi-system complications. The limited number of patients available to participate in research studies can inhibit investigating sophisticated relationships. Secondary analysis is a research method that involves using existing data to answer new research questions. Data harmonization enables secondary analysis by combining data across studies, especially helpful for rare disease research where individual studies may be small. The National Heart, Lung, and Blood Institute Cure Sickle Cell Initiative (CureSCi) Metadata Catalog is a web-based tool to identify SCD study datasets for conducting data harmonization and secondary analysis. We present a proof-of-concept secondary analysis to explore factors associated with discontinuation of hydroxyurea, a safe and effective first line SCD therapy, to illustrate the utility of the CureSCi Metadata Catalog to expedite and enable more robust SCD research. Methods We performed secondary analysis of SCD studies using a multi-step workflow: develop research questions, identify study datasets, identify variables of interest, harmonize variables, and establish an analysis method. A harmonized dataset consisting of eight predictor variables across five studies was created. Secondary analysis involved a generalized linear model was employed to identify factors that significantly impact hydroxyurea discontinuation. Results The CureSCi Metadata Catalog provided a platform to efficiently find relevant studies and design a harmonization strategy to prepare data for secondary analysis. Multivariate analysis of the harmonized identified that patients who are older, are female, had a history of blood transfusion therapy, had episodes of acute chest syndrome, and had the SC sickle cell genotype are more likely to stop hydroxyurea treatment. Conclusion This secondary analysis provides a template for how the CureSCi Metadata Catalog expedites dataset discovery of sickle cell studies for identifying relationships between variables or validating existing findings.
- Open Access
- 17 March 2023
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 65 (3) , 534-542
The PhenX Toolkit: Measurement Protocols for Assessment of Social Determinants of Health
- 17 March 2023
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 65 (3) , 534-542
Open AccessThe PhenX Toolkit: Measurement Protocols for Assessment of Social Determinants of Health
- Open Access
- 28 March 2022
- Published by Springer Nature in Journal of Exposure Science & Environmental Epidemiology
- Vol. 33 (1) , 12-16
Linking complex disease and exposure data—insights from an environmental and occupational health study
The disparate measurement protocols used to collect study data are an intrinsic barrier to combining information from environmental health studies. Using standardized measurement protocols and data standards for environmental exposures addresses this gap by improving data collection quality and consistency. To assess the prevalence of environmental exposures in National Institutes of Health (NIH) public data repositories and resources and to assess the commonality of the data elements, we analyzed clinical measures and exposure assays by comparing the Caribbean Consortium for Research in Environmental and Occupational Health study with selected NIH environmental health resources and studies. Our assessment revealed that (1) environmental assessments are widely collected in these resources, (2) biological assessments are less prevalent, and (3) NIH resources can help identify common data for meta-analysis. We highlight resources to help link environmental exposure data across studies to support data sharing. Including NIH data standards in environmental health research facilitates comparing and combining study data, and the use of NIH resources and adoption of standard measures will allow integration of multiple studies and increase the scientific impact of individual studies.
- 28 March 2022
- Published by Springer Nature in Journal of Exposure Science & Environmental Epidemiology
- Vol. 33 (1) , 12-16
Open AccessLinking complex disease and exposure data—insights from an environmental and occupational health study
The disparate measurement protocols used to collect study data are an intrinsic barrier to combining information from environmental health studies. Using standardized measurement protocols and data standards for environmental exposures addresses this gap by improving data collection quality and consistency. To assess the prevalence of environmental exposures in National Institutes of Health (NIH) public data repositories and resources and to assess the commonality of the data elements, we analyzed clinical measures and exposure assays by comparing the Caribbean Consortium for Research in Environmental and Occupational Health study with selected NIH environmental health resources and studies. Our assessment revealed that (1) environmental assessments are widely collected in these resources, (2) biological assessments are less prevalent, and (3) NIH resources can help identify common data for meta-analysis. We highlight resources to help link environmental exposure data across studies to support data sharing. Including NIH data standards in environmental health research facilitates comparing and combining study data, and the use of NIH resources and adoption of standard measures will allow integration of multiple studies and increase the scientific impact of individual studies.
- 1 March 2018
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 343, 71-83
AOP-DB: A database resource for the exploration of Adverse Outcome Pathways through integrated association networks
- 1 March 2018
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 343, 71-83
AOP-DB: A database resource for the exploration of Adverse Outcome Pathways through integrated association networks